ATOS icon

Atossa Therapeutics
ATOS

Overview Fund Activity

54 hedge funds and large institutions have $22.8M invested in Atossa Therapeutics in 2021 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 3 closing their positions.

Holders
54
Holders Change
+35
Holders Change %
+184.21%
% of All Funds
0.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
38
Increased
11
Reduced
3
Closed
3
Calls
$10.2M
Puts
$4.57M
Net Calls
+$5.65M
Net Calls Change
+$5.6M

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$6.97M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$6.71M
3
BlackRock
3
BlackRock
New York
$3.23M
4
CH
4
CVI Holdings
Delaware
$912K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$1.03M

Top Sellers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$104K
2
Citadel Advisors
2
Citadel Advisors
Florida
$72K
3
VF
3
Virtu Financial
New York
$574K
Name Market Value Shares Shares
Change 		Shares
Change %
AF
51
Allworth Financial
California
$1K 702 +702 New
MIH
52
Meitav Investment House
Israel
$63 30,000 +30,000 New
TWA
53
TCI Wealth Advisors
Arizona
– – -400 Closed
Simplex Trading
54
Simplex Trading
Illinois
– – -400 Closed
Group One Trading
55
Group One Trading
Illinois
– – -100 Closed
PCM
56
Prelude Capital Management
New York
– – – –
HT
57
HAP Trading
New York
– – – –
MTIM
58
Marathon Trading Investment Management
Pennsylvania
– – – –
CM
59
Caption Management
Oklahoma
– – – –
IA
60
IFP Advisors
Florida
– – – –
CFGS
61
Concourse Financial Group Securities
Alabama
– – – –
EVM
62
Eaton Vance Management
Massachusetts
$0 5 +5 New
EP
63
Eudaimonia Partners
Tennessee
$0 54 +54 New
1 2
3